Europe Approves Three Groundbreaking Cancer Drugs: New Hope for Patients
01 Feb 2025
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recently approved three new cancer medicines for marketing authorization, offering new hope in the fight against some of the most challenging cancers. These groundbreaking treatments include Datroway (datopotamab deruxtecan) for advanced breast cancer, Tivdak...
Read More